… and choosing optimal immunotherapy for patients with severe … discuss promising
immunotherapies for COVID-19, including … recent advances in the development of COVID-19 …

… microvascular injury in COVID-19 patients, complement genetics as a potential clue to race
differences in COVID-19 severity, options to target complement in COVID-19 patients with …

… Immunotherapy can offer a potential treatment to coronavirus disease 2019 (COVID-19) the
… a potential treatment strategy to help combat COVID-19. Cancer patients are at the top of the …

… , and immunotherapy may have significant potential in the treatment of COVID-19. Based
on … against COVID-19 and provide a summary from traditional and newer methods in curing …

… COVID‐19 is a historic pandemic that is testing populations, … immunotherapies to manage
COVID‐19 may prove to be effective agents in the fight against SARS‐CoV‐2 and COVID‐19. …

… acute respiratory distress (ARDS) in COVID-19. We aimed to investigate the effect of
personalized immunotherapy on clinical improvement of critical COVID-19. Methods: In this open-…

… severe COVID-19 symptoms and immunotherapy compared … between patient outcome and
recent immunotherapy (<4 weeks… inhibitor (CPI) immunotherapy, chemotherapy, combination …

… The coronavirus disease 2019 pandemic raised the need to extend venom immunotherapy
(VIT) time intervals safely. However, no guidelines are currently available on how to manage …

… as suboptimal responses to COVID-19 vaccines, rendering … at a heightened vulnerability
to develop COVID-19 disease. Thus, … responses associated with COVID-19. Furthermore, the …

… and safety of COVID-19 vaccines for patients with solid … Therefore, we aimed to assess the
impact of immunotherapy, … ) COVID-19 vaccine as part of the Vaccination Against COVID in …